0

    540694

    ANG

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    ANG Lifesciences India Limited Share Price Today

    Investment Returns

    Over 1 Month 19.51% Over 3 Months 51.76% Over 6 Months 19.67% Over 1 Year 12.03%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    ANG Lifesciences India Limited fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 42.60
    • P/E Ratio (TTM) -9.49
    • Beta 0.56
    • Book Value / share 47.64
    • Return on equity -14.37%
    • EPS (TTM) 0.00
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 1.10
    info icon alternate text

    ANG Lifesciences India Limited Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 22.80
    Operating Expense 21.56
    Net Profit 1.10
    Net Profit Margin (%) 4.82
    Earnings Per Share (EPS) 0.90
    EBITDA 4.81
    Effective Tax Rate (%) 23.07
    Particulars DEC 2025 (Values in Cr)
    Revenue 18.30
    Operating Expense 23.43
    Net Profit -4.24
    Net Profit Margin (%) -23.16
    Earnings Per Share (EPS) -3.23
    EBITDA -1.92
    Effective Tax Rate (%) 14.85
    Particulars SEP 2025 (Values in Cr)
    Revenue 25.97
    Operating Expense 26.80
    Net Profit -0.80
    Net Profit Margin (%) -3.08
    Earnings Per Share (EPS) -0.60
    EBITDA 2.42
    Effective Tax Rate (%) -29.03
    Particulars JUN 2025 (Values in Cr)
    Revenue 24.53
    Operating Expense 25.74
    Net Profit -0.79
    Net Profit Margin (%) -3.22
    Earnings Per Share (EPS) -0.59
    EBITDA 2.03
    Effective Tax Rate (%) 23.30
    Particulars MAR 2025 (Values in Cr)
    Revenue 17.67
    Operating Expense 21.37
    Net Profit -1.94
    Net Profit Margin (%) -10.97
    Earnings Per Share (EPS) -1.50
    EBITDA 0.38
    Effective Tax Rate (%) 34.45
    Particulars MAR 2026 (Values in Cr)
    Revenue 91.60
    Operating Expense 97.52
    Net Profit -4.73
    Net Profit Margin (%) -5.16
    Earnings Per Share (EPS) -3.52
    EBITDA 7.34
    Effective Tax Rate (%) 8.86
    Particulars MAR 2025 (Values in Cr)
    Revenue 89.91
    Operating Expense 105.28
    Net Profit -10.34
    Net Profit Margin (%) -11.50
    Earnings Per Share (EPS) -7.86
    EBITDA 0.62
    Effective Tax Rate (%) 20.01
    Particulars MAR 2024 (Values in Cr)
    Revenue 131.37
    Operating Expense 139.34
    Net Profit -8.65
    Net Profit Margin (%) -6.58
    Earnings Per Share (EPS) -6.48
    EBITDA 8.21
    Effective Tax Rate (%) 2.48
    Particulars MAR 2023 (Values in Cr)
    Revenue 207.01
    Operating Expense 214.76
    Net Profit -0.66
    Net Profit Margin (%) -0.31
    Earnings Per Share (EPS) 0.04
    EBITDA 20.91
    Effective Tax Rate (%) 131.88
    Particulars MAR 2022 (Values in Cr)
    Revenue 348.67
    Operating Expense 296.56
    Net Profit 39.71
    Net Profit Margin (%) 11.38
    Earnings Per Share (EPS) 38.51
    EBITDA 66.03
    Effective Tax Rate (%) 25.16
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 45.40
    ROE % -17.70
    ROCE % -4.41
    Total Debt to Total Equity 1.11
    EBITDA Margin 0.12
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 54.82
    ROE % -10.56
    ROCE % 1.43
    Total Debt to Total Equity 0.88
    EBITDA Margin 7.28
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 62.43
    ROE % -0.21
    ROCE % 8.31
    Total Debt to Total Equity 0.87
    EBITDA Margin 10.74
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 76.28
    ROE % 48.13
    ROCE % 35.05
    Total Debt to Total Equity 0.92
    EBITDA Margin 19.42
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 50.88
    ROE % -14.37
    ROCE % -3.80
    Total Debt to Total Equity 0.90
    EBITDA Margin 1.08
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 58.74
    ROE % -8.72
    ROCE % 1.71
    Total Debt to Total Equity 0.71
    EBITDA Margin 7.78
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 61.91
    ROE % -0.46
    ROCE % 7.81
    Total Debt to Total Equity 0.69
    EBITDA Margin 9.99
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 76.00
    ROE % 63.62
    ROCE % 49.10
    Total Debt to Total Equity 0.83
    EBITDA Margin 19.07
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 76.99
    ROE % 19.10
    ROCE % 19.05
    Total Debt to Total Equity 0.83
    EBITDA Margin 10.42
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 3.63
    Total Assets 229.59
    Total Liabilities 229.59
    Total Equity 63.97
    Share Outstanding 1
    Price to Book Ratio 0.45
    Return on Assets (%) -5.40
    Return on Capital (%) -8.6
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 5.73
    Total Assets 242.43
    Total Liabilities 242.43
    Total Equity 76.27
    Share Outstanding 1
    Price to Book Ratio 0.77
    Return on Assets (%) -4.18
    Return on Capital (%) -6.97
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 6.17
    Total Assets 277.66
    Total Liabilities 277.66
    Total Equity 86.21
    Share Outstanding 1
    Price to Book Ratio 1.23
    Return on Assets (%) -0.09
    Return on Capital (%) -0.17
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 6.65
    Total Assets 291.03
    Total Liabilities 291.03
    Total Equity 83.76
    Share Outstanding 1
    Price to Book Ratio 3.09
    Return on Assets (%) 13.85
    Return on Capital (%) 25.08
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 3.55
    Total Assets 208.66
    Total Liabilities 208.66
    Total Equity 66.80
    Share Outstanding 1
    Price to Book Ratio 0.45
    Return on Assets (%) -4.95
    Return on Capital (%) -7.68
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 5.49
    Total Assets 217.42
    Total Liabilities 217.42
    Total Equity 77.07
    Share Outstanding 1
    Price to Book Ratio 0.77
    Return on Assets (%) -3.97
    Return on Capital (%) -6.51
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 6.05
    Total Assets 252.50
    Total Liabilities 252.50
    Total Equity 85.53
    Share Outstanding 1
    Price to Book Ratio 1.23
    Return on Assets (%) -0.26
    Return on Capital (%) -0.48
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 6.58
    Total Assets 268.68
    Total Liabilities 268.68
    Total Equity 83.48
    Share Outstanding 1
    Price to Book Ratio 3.09
    Return on Assets (%) 14.78
    Return on Capital (%) 27.49
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.11
    Total Assets 142.24
    Total Liabilities 142.24
    Total Equity 41.35
    Share Outstanding 0
    Price to Book Ratio 1.11
    Return on Assets (%) 5.09
    Return on Capital (%) 8.66
    Particulars MAR 2025 (Values in Cr)
    Net Income -15.70
    Cash from Operations 3.97
    Cash from Investing -1.58
    Cash from Financing 1.68
    Net change in Cash -0.16
    Free Cash Flow 7.72
    Particulars MAR 2024 (Values in Cr)
    Net Income -10.71
    Cash from Operations 3.91
    Cash from Investing 19.89
    Cash from Financing -10.40
    Net change in Cash 0.00
    Free Cash Flow 9.48
    Particulars MAR 2023 (Values in Cr)
    Net Income 2.62
    Cash from Operations 29.83
    Cash from Investing -9.32
    Cash from Financing -17.07
    Net change in Cash -0.02
    Free Cash Flow 40.28
    Particulars MAR 2022 (Values in Cr)
    Net Income 53.50
    Cash from Operations 25.24
    Cash from Investing -44.40
    Cash from Financing 19.92
    Net change in Cash 0.23
    Free Cash Flow 66.58
    Particulars MAR 2025 (Values in Cr)
    Net Income -12.93
    Cash from Operations 1.89
    Cash from Investing -1.62
    Cash from Financing 3.91
    Net change in Cash 0.00
    Free Cash Flow 6.01
    Particulars MAR 2024 (Values in Cr)
    Net Income -8.86
    Cash from Operations 0.26
    Cash from Investing 20.01
    Cash from Financing -7.00
    Net change in Cash -0.11
    Free Cash Flow 5.70
    Particulars MAR 2023 (Values in Cr)
    Net Income 2.06
    Cash from Operations 29.36
    Cash from Investing -9.34
    Cash from Financing -16.74
    Net change in Cash -0.08
    Free Cash Flow 39.80
    Particulars MAR 2022 (Values in Cr)
    Net Income 53.06
    Cash from Operations 27.97
    Cash from Investing -42.50
    Cash from Financing 15.28
    Net change in Cash 0.17
    Free Cash Flow 67.31
    Particulars MAR 2021 (Values in Cr)
    Net Income 9.86
    Cash from Operations -10.55
    Cash from Investing -7.78
    Cash from Financing 18.80
    Net change in Cash -0.16
    Free Cash Flow -6.48
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.72 13.52 1.58 250.74 23.12 38.85
    BLISS GVS PHARMA LTD 506.15 40.69 4.49 5368.04 118.35 552.90
    CIPLA LTD 1458.45 30.95 3.42 117820.20 1165.55 1672.20
    FERMENTA BIOTECH LTD. 345.85 15.26 2.50 1017.87 256.40 399.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.72 22.88 4.21 250.74 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 536.85 24.06 4.19 1552.07 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8297.90 108.37 23.76 20744.75 7630.00 9850.00
    BLISS GVS PHARMA LTD 506.15 54.72 4.64 5368.04 118.35 552.90

    ANG Lifesciences India Limited shareholding pattern

    Holding
    29.39%
    70.6%
    44.88%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    ANG Lifesciences India Limited Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    32.65 -4.97 redarrow
    red-green-graph indicator
    9 Bearish
    7 Bullish
    • 5 Days 36.10
    • 26 Days 33.10
    • 10 Days 35.80
    • 50 Days 30.80
    • 12 Days 35.40
    • 100 Days 29.00
    • 20 Days 34.00
    • 200 Days 29.20
    34.40 PIVOT
    First Support 33.16 First Resistance 35.61 Second Support 31.95 Second Resistance 36.85 Third Support 30.71 Third Resistance 38.06
    RSI 53.65 ADX 34.03 MACD 2.28 Williams % R -67.56 Commodity Channel Index (CCI) 21.28
    Date 2026-07-03 Week 13071.00 Same Day 13296.00 Month 12733.00
    1 Year 0.57 3 Year 0.24
    Over 1 Month
    19.51% down
    Over 1 Year
    12.03% down
    Over 3 Months
    51.76% down
    Over 3 Years
    -20.20% down
    Over 6 Months
    19.67% down
    Over 5 Years
    -6.42% down

    ANG Lifesciences India Limited Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    02 Nov 2021 1.0 Interim 04 Nov 2021 Equity shares
    Ex-Date Ex-Bonus Ratio
    14 Jul 2022 13 Jul 2022 1:4
    23 Sep 2021 22 Sep 2021 1:1

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of ANG Lifesciences India Ltd?

    Answer Field

    ANG Lifesciences India Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 32.65 as on Jul 06 2026 03:29 PM.

    What is the Market Cap of ANG Lifesciences India Ltd Share?

    Answer Field

    The market cap of ANG Lifesciences India Ltd for NSE ₹ 0.00 & for BSE ₹ 42.60 as on Jul 06 2026 03:29 PM.

    What is the 52 Week High and Low of ANG Lifesciences India Ltd?

    Answer Field

    The 52 Week High and Low of ANG Lifesciences India Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 49.69 and ₹ 17.63.

    What is 1 year return for ANG Lifesciences India Ltd?

    Answer Field

    The 1 year returns on the stock has been 12.03%.

    What is the P/E Ratio of ANG Lifesciences India Ltd Share?

    Answer Field

    As on Jul 06 2026 03:29 PM the price-to-earnings (PE) ratio for ANG Lifesciences India Ltd share is -9.49.

    What is the PB ratio of ANG Lifesciences India Ltd Share?

    Answer Field

    As on Jul 06 2026 03:29 PM, the price-to-book (PB) ratio for ANG Lifesciences India Ltd share is 47.64.

    How to Buy ANG Lifesciences India Ltd Share?

    Answer Field

    You can trade in ANG Lifesciences India Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy ANG Lifesciences India Ltd Share on Bajaj Broking App?

    Answer Field

    To buy ANG Lifesciences India Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “ANG Lifesciences India Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |